We’re here to help you achieve your strategic objectives.
Q1 2026 Healthcare M&A Spotlight
April 17, 2026 | Insights
We expect Q2 deal activity to come in moderately above Q1 levels. We are noticing an uptick in process re-launches for transactions that stalled in the 2023-2025 window, and pitch activity continues to be elevated compared to last year. We should continue to see high multiples for good assets in in-demand sectors. This report explores broad M&A market trends and insights into Bailey & Company’s four main coverage areas: healthcare services, healthcare IT & tech-enabled services, payer services, and pharma services, life sciences & medtech.
Download the report by filling out the form. Please contact us to request more information.
Download Now
CONTACT INFORMATION
Rebecca Springer
Senior Director, Market Development
Collin Anderson
Senior Analyst, Market Development
ABOUT BAILEY & COMPANY
Bailey & Company is a Nashville-based merchant banking platform focused on middle market healthcare companies in the healthcare services, healthcare technology, payer services and pharma services/medtech/life sciences sectors. As one of the largest independent, sector-focused investment banking and investing platforms in the country, Bailey & Company supports strong management teams that have built scalable platforms by providing strategic insights, world-class advice and access to one of the most diverse networks of industry experts. For more information see: www.bnco.com
